Literature DB >> 8972760

Morphological variability of tumour cells in T-cell-rich B-cell lymphoma. A histopathological study of 14 cases.

S Camilleri-Bröet1, T Molina, J Audouin, A L Tourneau, J Diebold.   

Abstract

T-cell-rich B-cell lymphoma (TCRBCL) is an unusual lymphoma which is difficult to diagnose. A majority of reactive T-cells and numerous histiocytes mask the few large neoplastic B-cells. Fourteen cases of TCRBCL were studied in order to identify the main histological and cytological features useful for this diagnosis. Neoplastic cells are atypical and sometimes difficult to classify. Several types are seen; they are mostly centroblasts, which represent more than 50% of the tumour cells but are sometimes multilobated, immunoblasts- or Reed-Sternberg-like cells. Interestingly, at least two, and often three, types of tumour cell are present in all the cases. Epithelioid cells and histiocytes are always found and are often numerous. Hypervascularization and fibrosis are present in the majority of cases, but without annular bands. Necrosis is absent. All tumour cells express CD20 but EMA is expressed in less than half the cases. In two cases, the association of a diffuse large B-cell lymphoma in one site and a TCRBCL in another suggests that TCRBCL may be considered as a peculiar pattern of a diffuse large B-cell lymphoma with a strong stroma reaction. TCRBCL may not represent a clinicopathological entity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8972760     DOI: 10.1007/bf00198340

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  18 in total

1.  Clinical correlates of distinct immunophenotypic and histologic subcategories of lymphocyte-predominance Hodgkin's disease.

Authors:  A Tefferi; R A Zellers; P M Banks; T M Therneau; J P Colgan
Journal:  J Clin Oncol       Date:  1990-12       Impact factor: 44.544

2.  Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.

Authors:  J Delabie; E Vandenberghe; C Kennes; G Verhoef; M P Foschini; M Stul; J J Cassiman; C De Wolf-Peeters
Journal:  Am J Surg Pathol       Date:  1992-01       Impact factor: 6.394

3.  Large B-cell lymphoma rich in T-cells and simulating Hodgkin's disease.

Authors:  S M Chittal; P Brousset; J J Voigt; G Delsol
Journal:  Histopathology       Date:  1991-09       Impact factor: 5.087

4.  B-cell lymphomas morphologically resembling T-cell lymphomas.

Authors:  I Mirchandani; M Palutke; P Tabaczka; S Goldfarb; L Eisenberg; M S Pak
Journal:  Cancer       Date:  1985-10-01       Impact factor: 6.860

5.  An autopsied case of T-cell rich B-cell lymphoma with general involvement.

Authors:  K Tajima; N Fukase; T Shiono; T Katagiri; S Mito
Journal:  Intern Med       Date:  1995-04       Impact factor: 1.271

6.  T-cell-rich B-cell lymphoma presenting as liver disease.

Authors:  S M Khan; B J Cottrell; G H Millward-Sadler; D H Wright
Journal:  Histopathology       Date:  1993-09       Impact factor: 5.087

7.  T-cell-rich B-cell lymphoma of the spleen.

Authors:  H F Betman; J W Vardiman; J Lau
Journal:  Am J Surg Pathol       Date:  1994-03       Impact factor: 6.394

8.  Large B-cell lymphomas with a high content of reactive T cells.

Authors:  C S Ng; J K Chan; P K Hui; W H Lau
Journal:  Hum Pathol       Date:  1989-12       Impact factor: 3.466

9.  T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease: two closely related entities?

Authors:  U Schmidt; K A Metz; L D Leder
Journal:  Br J Haematol       Date:  1995-06       Impact factor: 6.998

Review 10.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

View more
  1 in total

1.  Pediatric lymphomas in Brazil.

Authors:  Gabriela Gualco; Claudete E Klumb; Glen N Barber; Lawrence M Weiss; Carlos E Bacchi
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.